secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000313143-24-000060
Event type: earnings
Sentiment:  neutral
Materiality: 0.20
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics announces Q2 FY2025 results; specific figures unavailable from provided filing text
--------------------------------------------------------------------------------

- Company issued press release for quarter ended Sept 28, 2024 and first half of fiscal 2025.
- No revenue, EPS, or segment data are included in the 8-K filing text provided.
- Investors should consult the full press release for detailed financial results.
- CEO Christopher A. Simon signed the Form 8-K on November 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/0000313143-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/hae-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer